Search Results
Displaying 41 - 50 of 1221
On this page
What is intracranial atherosclerotic disease?Intracranial atherosclerotic disease (ICAD) is one of the main causes of stroke. ICAD happens when the arteries in the brain become hard, thick, and narrow. This is caused by a buildup of plaque (fatty deposits) inside the artery walls in the brain. This narrowing of artery walls, called stenosis, means less blood flows to areas of the brain supplied by the affected artery. If the blood flow is blocked completely,…
… we diagnose and treat patients with previously undiagnosed diseases. The Undiagnosed Diseases Network (UDN) is a … and is led by the National Institute of Neurological Disorders and Stroke ( NINDS ). Launched by the NIH Office … of the Director. With help from patients, family members, patient advocacy groups, a Data Management and Coordinating …
… therapies for people living with amyotrophic lateral sclerosis (ALS) or at risk for developing ALS. The AMP ® … ), Alzheimer’s disease ( AMP ® AD ), amyotrophic lateral sclerosis ( AMP ® ALS ), and several others with the common … the Newsletter and Sign Up About Amyotrophic Lateral Sclerosis (ALS) ALS is a rapidly progressing, …
… with and can be difficult to distinguish from AD. In fact, more often than not, patients with a clinical diagnosis … by NINDS Council and/or forecasted. Please note that this page will be periodically updated with links when funding …
… on a variety of dementias and other neurological disorders. The National Institute on Aging (NIA) offers … and other forms of dementia on its Alzheimer’s Disease Education and Referral (ADEAR) website. The National Heart, Lung, and Blood Institute (NHLBI) offers patient information in English and Spanish . MedlinePlus …
… Tuesday, February 28, 2023 Rare and ultra-rare diseases affect millions of people worldwide. Today, roughly … affect the nervous system, and almost 90% of rare disorders can occur in children. For years, the NIH and NINDS … researchers and their teams work together with over 120 patient organizations (patient advocacy groups) to study …
… swallowing and facial movements. Myasthenia gravis is an autoimmune disease, which means that the body’s defense … developing targeted gene therapy for treating the disorders. Causes of myasthenia gravis Myasthenia gravis is … research will help reveal new therapies for neuromuscular diseases like myasthenia gravis. Researchers are also …
… Tuesday, April 29, 2025 Each April, during Parkinson’s Awareness Month, I take a moment to reflect on the progress … findings from the Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease trial. In 2015, NIH-funded … Parkinson’s disease ranks as the second most common …
… of new therapeutic interventions for neurological disorders. Learn more about translational research … This is a landing page that includes information on NINDS-supported research on … of new therapeutic interventions for neurological disorders. …